Galedra
Sign in Sign up

Source

Use of long-acting broadly neutralizing antibodies may delay HIV rebound following discontinuation of antiretroviral therapy SECONDARY_TEXT

2 Minute Medicine · no page hash: the reader saw a rendering, not the bytes · created seq 16945

Link: https://www.2minutemedicine.com/use-of-long-acting-broadly-neutralizing-antibodies-may-delay-human-immunodeficiency-virus-hiv-rebound-following-discontinuation-of-antiretroviral-therapy/ · read at 2026-09-29T01:45:00Z · held by reference: only the link, the quoted excerpts with their hashes, and the page hash when the reader had the bytes are stored

Retrieval by Galedra

FETCHED at 2026-09-29T01:29:09Z · https://www.2minutemedicine.com/use-of-long-acting-broadly-neutralizing-antibodies-may-delay-human-immunodeficiency-virus-hiv-rebound-following-discontinuation-of-antiretroviral-therapy/ · seq 18962

Server hash sha256:099ef056fa07b1a0fea108b32842d820e5ecc0439009f764dfc9e07457c22256 · 300128 bytes · text/html. The reader's record is unchanged; this is the server's finding beside it.

ExcerptFinding
Early viral rebound before week 20 occurred in 8 participants in the bNAb group versus 30 in the placebo group ... Median time to ART restart was 45.4 weeks ...not found — this server looked at the page and did not find the passage

Claims from this source

No claims have been extracted from this source yet.

Locations

LocatorExcerpt
QUOTE {}Early viral rebound before week 20 occurred in 8 participants in the bNAb group versus 30 in the placebo group ... Median time to ART restart was 45.4 weeks in the bNAb group compared with 4.6 weeks in the control group.

Claims citing this source